Citigroup
ATTO

Citigroup’s Attovia Therapeutics ATTO Stock Holding History

Citigroup’s Portfolio ATTO Stock Details ATTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$21.2K Buy
+1,237
New +$26K ﹤0.01% 4980

Other funds holding ATTO

Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Citigroup's ATTO Position: Q3 2026 in Review

Citigroup opened a new position in Attovia Therapeutics (ATTO) in Q3 2026: 1,237 shares worth $21.2K. The stake represents ﹤0.01% of the portfolio and ranks #4980 among its holdings.

4 funds tracked by Wall St. Rank hold ATTO as of Q3 2026.

  • Citigroup held 1,237 shares of Attovia Therapeutics worth $21.2K as of Q3 2026.
  • Attovia Therapeutics was a new Citigroup position in Q3 2026.
  • Attovia Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #4980 holding.
  • 4 funds tracked by Wall St. Rank held Attovia Therapeutics as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.